The evidence for that hypothesis is strong, at least for one of the more robust schizophrenia gene candidates— Dysbindin—a team of German scientists reported in the April NeuroImage. The lead researcher was Thomas Nickl-Jockschat, M.D., director of the Clinic for Psychiatry, Psychotherapy, and Psychosomatics at the University of Aachen.